🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Karn Wijarnpreecha

University of Arizona

ORCID: 0000-0002-6232-6343

Also affiliated with University of Phoenix, Banner - University Medical Center Phoenix, Phoenix College

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.3Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021

Clinical and Molecular Hepatology(2025)10.3350/cmh.2024.0835
Top 23%
0.872DataRank
Top 23%60 citations

Luis Antonio Díaz, Kanokphong Suparan, Primrose Tothanarungroj, Supapitch Sirimangklanurak, Thanida Auttapracha +18 more

Papers

Driven by 10 papers — median percentile 68. Top paper: “Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021”.

Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021

Clinical and Molecular Hepatology(2025)10.3350/cmh.2024.0835
Top 23%
0.872DataRank
Top 23%60 citations

Luis Antonio Díaz, Kanokphong Suparan, Primrose Tothanarungroj, Supapitch Sirimangklanurak, Thanida Auttapracha +18 more

Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries

Cancer(2025)10.1002/cncr.70245
Top 40%
0.476DataRank
Top 40%18 citations

Yanfang Pang, Primrose Tothanarungroj, Disatorn Dejvajara, Donghee Kim, Preenapun Saokhieo +12 more

Burden of Alcohol‐Related Liver Disease and Alcohol Use Disorder in Asia

United European Gastroenterology Journal(2025)10.1002/ueg2.70077
N/A
0DataRank · unranked
12 citations

Yanfang Pang, Kanokphong Suparan, Preenapun Saokhieo, Pimtawan Jatupornpakdee, Natchaya Polpichai +11 more

Alcohol–Related Liver Disease, Followed by Metabolic Dysfunction–Associated Steatotic Liver Disease, Emerges as the Fastest‐Growing Aetiologies for Primary Liver Cancer in the United States

Alimentary Pharmacology & Therapeutics(2025)10.1111/apt.18473
N/A
0DataRank · unranked
13 citations

Kwanjit Duangsonk, Markos Kalligeros, Michael B. Fallon, Chawinthorn Vuthithammee, Chun‐Wei Pan +9 more

Mortality of Gastrointestinal Cancers Attributable to Smoking, Alcohol, and Metabolic Risk Factors, and its Association With Socioeconomic Development Status 2000-2021

The American Journal of Medicine(2025)10.1016/j.amjmed.2024.12.019
N/A
0DataRank · unranked
9 citations

Kanokphong Suparan, Yanfang Pang, Thanida Auttapracha, Ethan Kai Jun Tham, Chawinthorn Vuthithammee +12 more

Letter: Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Related Liver Cancer—Results From the Global Burden of Disease Study 2021. Authors' Reply

Alimentary Pharmacology & Therapeutics(2025)10.1111/apt.18520
N/A
0DataRank · unranked
0 citations

Donghee Kim, Markos Kalligeros, Amit G. Singal, Ju Dong Yang, Karn Wijarnpreecha +1 more

Evolving Public Attention to Steatotic Liver Disease: A 20‐Year Analysis (2004–2024)

Journal of Gastroenterology and Hepatology(2025)10.1111/jgh.17009
N/A
0DataRank · unranked
0 citations

Charat Thongprayoon, Kanokphong Suparan, Donghee Kim, Ornpailin Wanichthanaolan, Phuuwadith Wattanachayakul +8 more

PNPLA3 Genotype and Diabetes Identify Patients With Nonalcoholic Fatty Liver Disease at High Risk of Incident Cirrhosis

Gastroenterology(2023)10.1053/j.gastro.2023.01.040
N/A
0DataRank · unranked
100 citations

Antonino Oliveri, Matthew J. Miller, Karn Wijarnpreecha, Xiaomeng Du, Yanhua Chen +4 more

Impact of Model for End-stage Liver Disease 3.0 on Waitlist Outcomes of Metabolic Dysfunction-associated Steatohepatitis Cirrhosis Among Liver Transplant Candidates

Clinical Gastroenterology and Hepatology(2025)10.1016/j.cgh.2025.10.016
N/A
0DataRank · unranked
0 citations

Darren Jun Hao Tan, Kartik Mitra, Margaret Teng, Cheng Han Ng, Donghyun Ko +15 more

Global Trend of MASH-associated Liver Cancer: A Systematic Analysis From the Global Burden of Disease 2021

Clinical Gastroenterology and Hepatology(2024)10.1016/j.cgh.2024.10.026
N/A
0DataRank · unranked
12 citations

Kanokphong Suparan, Chuthatip Kaeosri, Pimtawan Jatupornpakdee, Abdelrahman M. Attia, Thanathip Suenghataiphorn +8 more